From various announcements
2018
The Company’s analysis of the first lot of 300mm wafers from imec has enabled management and imec to identify with confidence the necessary modifications required to enhance the development of the second 300mm wafer lot, which will be available for analysis in Q1 2019.
IE: They weren't functional
In late January 2019, 4DS announced that imec had fabricated functional 300mm wafers
On 20 February 2019, 4DS announced that imec had produced 23 testable 300mm wafers
AUG 2020
B. Initial Platform Lot Testing of the Initial Platform Lot validated the integration process steps required to integrate 4DS memory cells with imec’s megabit platform. The information gathered from this testing has enabled 4DS to identify which process steps will be further tuned, to benefit future platform iterations.
Nov 2020 overview
- Completed Additional Wafers Lot of 300mm wafers, most successful to date
- 4DS is developing a breakthrough Interface Switching ReRAM Storage Class Memory solution
- Recently produced pivotal data applicable for Storage Class Memory and best to date
.
.
.
Is it just me or do the first platform lot results read like the very first wafer results out of imec ? Was the first platform lot "functional" or not.
Developing a solution
Producing pivotal data
You can read that a myriad of ways like our very first wafer lot.
Geez I hope this next cake with all the bells & whistle ingredients baked in is Functional. I'm still wary. Very wary.
I think Wilbert or whomever is just going all out for Gold and throwing the kitchen sink at this one.
Let's hope it works. If it doesn't, at least we know we are a good few years ahead of any competitors that might show up on the scene. A few more capital raises to boot no doubt.
- Forums
- ASX - By Stock
- 4DS
- Ann: Appendix 4D & Half-Year Financial Report
Ann: Appendix 4D & Half-Year Financial Report, page-30
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $255.0K | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 0.088 |
8 | 774567 | 0.087 |
5 | 576804 | 0.086 |
13 | 1368456 | 0.085 |
2 | 220000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 20000 | 1 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
0.093 | 181179 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online